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Abstract
Introduction: Central nervous system involvement is a rare but serious manifestation of brucellosis. We present an
unusual case of neurobrucellosis with transient ischemic attack, intracerebral vasculopathy granulomas, seizures,
and paralysis of sixth and seventh cranial nerves.
Case presentation: A 17-year-old Caucasian man presented with nausea and vomiting, headache, double vision
and he gave a history of weakness in the left arm, speech disturbance and imbalance. Physical examination
revealed fever, doubtful neck stiffness and left abducens nerve paralysis. An analysis of his cerebrospinal fluid
showed a pleocytosis (lymphocytes, 90%), high protein and low glucose levels. He developed generalized tonic-
clonic seizures, facial paralysis and left hemiparesis. Cranial magnetic resonance imaging demonstrated intracerebral
vasculitis, basal ganglia infarction and granulomas, mimicking the central nervous system involvement of
tuberculosis. On the 31st day of his admission, neurobrucellosis was diagnosed with immunoglobulin M and
immunoglobulin G positivity by standard tube agglutination test and enzyme-linked immunosorbent assay in both
serum and cerebrospinal fluid samples (the tests had been negative until that day). He was treated successfully
with trimethoprim and sulfamethoxazole, doxycyline and rifampicin for six months.
Conclusions: Our patient illustrates the importance of suspecting brucellosis as a cause of meningoencephalitis,
even if cultures and serological tests are negative at the beginning of the disease. As a result, in patients who have
a history of residence or travel to endemic areas, neurobrucellosis should be considered in the differential
diagnosis of any neurologic symptoms. If initial tests fail, repetition of these tests at appropriate intervals along
with complementary investigations are indicated.
Introduction
Brucellosis is still a common zoonotic infection in many
parts of the world, including North and East Africa, the
Middle East, South and Central Asia, South and Central
America, and the Mediterranean countries of Europe
[1]. Human brucellosis, typically, is acquired by inges-
tion of unpasteurized milk or cheese, by infected aero-
sols or through occupational exposure to infected
animals; in particular, sheep, goats, swine, camels and
cattle. Central nervous system involvement is a rare but
serious manifestation of brucellosis. Meningitis (acute,
subacute and chronic), meningoencephalitis, brain
abscess, epidural abscess, myelopathy, polyradiculitis,
mononeuritis and vascular involvements have been
reported as main clinical manifestation of neurobrucel-
losis [2,3]. We present a case with transient ischemic
attack (TIA), intracerebral vasculopathy granulomas
(which are extremely rare entities, with only a few cases
reported in the literature), seizures and cranial nerve
paralysis.
Case presentation
A previously healthy, 17-year-old Caucasian man suf-
fered headache, weakness in his left arm, hypoesthesia,
speech disturbance and imbalance, which resolved in a
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a doctor. Two weeks after this event, he was admitted
to our hospital due to worsening headache accompanied
by double vision, nausea, vomiting and fever. Physical
examination on admission revealed fever (38°C), doubt-
ful neck stiffness and left abducens nerve paralysis.
Kerning and Brudzinski signs were negative and all the
other systemic findings were non-specific. Laboratory
studies showed a leukocyte count of 5.9 × 10
3/μL( n e u -
trophils 55%, lymphocytes 45% and monocytes 5%), an
erythrocyte sedimentation rate of 2 mm/h, and a
C-reactive protein of 3.0 mg/dL (normal < 5.0 mg/dL).
Blood chemistry including liver enzymes and alkaline
phosphatase, prothrombin time, fibrinogen, antithrom-
bin III, protein C, protein S, activated protein C resis-
tance and antiphospholipid antibodies were within the
normal ranges. Immunologic markers including immu-
noglobulins, C3, C4, cryoglobulin, and antinuclear anti-
bodies were negative. The chest X-ray, cranial magnetic
resonance imaging (MRI) with contrast, abdominal
ultrasound and echocardiography were normal.
A lumbar puncture was performed and the investiga-
tion of cerebrospinal fluid (CSF) showed 104 cells/mL
(lymphocytes, 90%), a protein concentration of 250 mg/
dL, a glucose level of 22 mg/dL and the concurrent
blood glucose level of 72 mg/dL. Gram stain and Ziehl-
Nielsen stain, culture for bacteria, mycobacteria and
fungi were all negative. Serum and CSF Rose-Bengal,
standard tube agglutination (STA) test, Coombs’ test,
enyzyme-linked immunosorbent assay (ELISA) for
human immunodeficiency virus 1 and 2, Treponema
pallidum hemagglutination assay (TPHA) and Venereal
Disease Research Laboratories (VDRL) tests were nega-
tive. The purified protein derivative (PPD) skin test was
positive (11 × 11 mm). The diagnosis was considered as
possible tuberculosis meningitis and our patient was
empirically treated with isoniazid 600 mg, rifampicin
600 mg, pyrazinamide 1500 mg, ethambutol 1500 mg
and prednisolone 50 mg, daily. The fever subsided after
the third day and other clinical symptoms (such as dou-
ble vision and headache) resolved after six days of
therapy.
Although there was no worsening of his general con-
dition, fever reappeared on the tenth day. STA and
ELISA Brucella IgM and IgG antibodies were negative
again and these tests were repeated at weekly intervals
both in the samples of serum and CSF. The blood and
CSF cultures for bacteria including Brucella yielded no
growth.
On day 30 of his admission, our patient developed
generalized tonic-clonic seizures. The mild amplitude
slow wave activity was detected over the right hemi-
sphere on an electroencephalogram. Cranial computed
tomography (CT) showed a 1 cm diameter hypodense
nodule at left temporal lobe and a 1 cm hypodense
nodule next to the right thalamus anterior internal cap-
sid (the nodules were reported as tuberculomas by staff
of the radiology department). The following day he
experienced facial paralysis, left hemiparesis and head-
ache. Fever (38.2°C) and neck stiffness were observed.
MRI demonstrated an abnormal contrast enhancement
in the right sylvian fissure, millimetric nodular lesions in
the genus of the right capsula interna on T1-weighted
images, hyperintense infarct regions (about 10 mm in
right lentiforme nucleus and 20 mm in right caudal
nucleus) on T2-fluid attenuated inversion recovery
(FLAIR)-weighted images (Figure 1). The lesions were
reported as the ischemic process due to vasculitis sec-
ondary to tuberculosis and tuberculoma. On the same
day a fourth lumbar puncture (LP) was performed and
in the evaluation of CSF, the white blood count was
348/mL (lymphocytes 80%), protein 258 mg/dL, glucose
20 mg/dL, and the concurrent blood glucose was 88
mg/dL. Rose-Bengal, STA (1/160 in serum, 1/80 in CSF)
and ELISA IgM and IgG antibodies were positive in
both serum and CSF samples. Our patient was reques-
tioned for specific antecedents of systemic brucellosis;
he was a student from Southeastern Anatolia, where the
disease is endemic. A diagnosis of neurobrucellosis was
considered and treatment with trimethoprim/sulfa-
methoxazole (TMP/SMX) 160/800 mg three times a
day, doxycyline 200 mg/day and rifampicin 900 mg/day
was initiated. Fever disappeared ten days after the ther-
apy. Other signs and symptoms improved completely at
the end of the sixth month of therapy. Our patient
remains free of any complaints to date (a followup per-
iod of three years).
Discussion
Brucellosis still remains an important health problem in
developing countries and its incidence is increasing in
Turkey. Approximately 5600 cases annually were
reported between 1987 and 1996 (incidence: 9.6/
100,000) and around 13,800 cases annually were
reported to the Turkish Ministry of Health between
1997 and 2006 (incidence: 20.1/100,000). The seroposi-
tivity of brucellosis is 2.6 to 14.4% for the general Turk-
ish population [4].
The frequency with which Brucella attacks the CNS is
relatively low, with a reported incidence of 1.3% to 13%
[2,5]. Of the 101 brucellosis patients followed by our
clinic (between 2001 and 2008), eight had CNS involve-
ment (7.9%). Neurobrucellosis may involve several areas
of the central and peripheral nervous systems and may
develop at any stage of the disease. The most common
presentation is a typical meningitis or meningoencepha-
litis that has an acute and subacute onset, and can
occur either as the only site of infection or as part of
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cranial nerves, generally the eighth, has been noted in
the cases, especially as a manifestation of basal menin-
geal infection, while involvement of the sixth nerve is
very rare [6]. Our patient was admitted to our clinic
with an acute meningoencephalitis and sixth nerve palsy
and he experienced facial paralysis at the followup per-
iod, consistent with his basal involvement.
Cerebrovascular involvement of brucellosis is
explained by two mechanisms: the first mechanism is a
hemorrhagic stroke caused by rupture of a mycotic
aneurysm, which is probably a consequence of embolic
phenomenon from brucellar endocarditis; and the sec-
ond is an inflammatory process of the vessels or venous
system resulting in lacunar infarcts, small hemorrhages,
or venous thromboses. It was reported that there were
only a few cases in the literature of vasculopathic invol-
vement in neurobrucellosis [5,7-9]. Our patient gave a
history of weakness in the left arm, hypoesthesia, speech
disturbance and imbalance, which disappeared comple-
tely in a few hours; so this episode was defined as a
TIA. He experienced generalized tonic-clonic seizures,
facial paralysis, left hemiparesis during the following
period. MRI demonstrated lesions compatible with cere-
bral vasculitis. Although recently vasculitic involvement
in the cerebral arterial system was detected with digital
subtraction angiography in one case, angiography find-
ings of our patient showed no abnormality as in the
other reported patients in the literature. Al-Deep et al.
[5] described a case with left hemiplegia and CT
demonstrated a frontoparietal infarct, but cerebral
angiography was normal. The authors proposed that
normal findings of digital subtraction angiography was
consistent with vasculitic involvement of deep penetrat-
ing cerebral vessels.
Granulomas within the brain parenchyma are extre-
mely uncommon and have been reported in only four
cases (Table 1). Ciftci et al. [10] described a case with
visual impairment, bilateral hearing loss, hyperprolacti-
nemia, meningitis and a sellar and suprasellar mass,
who was treated successfully. Sohn et al. [11] reported
two cases of neurobrucellosis with an intracerebral gran-
u l o m ad u et oam a r i n em a m m a lBrucella sp.A n o t h e r
case report about a mass lesion in the parietal lobe due
to brucellosis was described by Miguel et al.[ 1 2 ] .A l -
Sous et al. [13] presented a case with neurobrucellosis
who had headache, deafness, papilledema, sensory
ataxia, areflexia, and a granuloma in the suprasellar
region. The authors reported a complete recovery with
documented radiologic improvement after four months
of medical treatment. On admission MRI was normal,
but a second MRI revealed cerebellar granulomas in the
patient.
The specific diagnosis of neurobrucellosis is based
upon seroagglutination and blood and CSF cultures
(positive <15% of the cases), which have relatively low
sensitivities. The finding of Brucella-specific antibodies
in the CSF is highly indicative of neurobrucellosis; how-
ever, since the antibodies are sometimes present at low
levels, agglutination tests commonly performed in the
diagnosis of the disease may give false-negative results.
ELISA is the recommended test whenever neurobrucel-
losis is clinically suspected, even though agglutination
tests and cultures were negative [3]. However, in con-
trast to previously reported cases, IgM and IgG antibo-
dies were negative by ELISA as well as Coombs’ test,
Figure 1 Post contrast T1-weighted MRI shows (A) a granuloma with peripheral enhancement in the genus of the right capsula
interna, and (B) an infarct in the basal ganglion due to vasculitis.
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day of the follow up. Unknown host factors, the rela-
tively short duration of his illness, and the applied ster-
oid therapy may be responsible for his lack of serologic
response, emphasizing the importance of high index of
suspicion of illness and repetition of the diagnostic tests
at appropriate intervals, and the use of novel diagnostic
technology, and, if possible, a molecular-based method
appear to be promising.
Tuberculosis is also an endemic disease in Turkey.
Neurotuberculosis includes three clinic categories:
meningitis, intracranial granuloma and spinal tubercu-
lous arachnoiditis. The disease presents with a CSF for-
mula characterized by lymphocytic pleocytosis, lowered
glucose concentration, and a high protein content, simi-
lar to neurobrucellosis. Hemiparesis (40.5%) and cranial
nerve palsies (35.7%) were the most common neurologi-
cal deficits. The prompt diagnosis and antibiotic treat-
ment of tuberculous meningitis save lives [14]. For this
reason, careful evaluation for CNS tuberculosis and bru-
cellosis is essential in a patient suspected of any of these
probable diagnoses, especially if the empirical therapy
fails.
There is no general consensus regarding the best treat-
ment for neurobrucellosis, but the use of doxycycline in
combination with two other drugs (rifampicin, TMP/
SMX, ceftriaxone) for at least three months is recom-
mended [3]. The mortality rate of neurobrucellosis in the
post-antibiotic era is 0 to 5.5%, but permanent neurologi-
cal deficits, particularly deafness, are common [2]. Our
patient was treated with doxycyline, rifampicin and
TMP/SMX for six months, without any sequelae.
Conclusions
Our patient illustrates the importance of suspecting bru-
cellosis as a cause of meningoencephalitis even if cul-
tures and serological tests are negative at the beginning
of the disease in an endemic area. It was interesting that
facial paralysis, vasculitic changes and granulomas devel-
oped in our patient during the followup period, mimick-
ing the CNS involvement of tuberculosis, which is also
endemic in Turkey. We conclude that brucellosis should
not be ruled out in patients who have a history of resi-
dence or travel to endemic areas and develop unex-
plained neurological symptoms.
Consent
Written informed consent was obtained from the
patient’s father for publication of this case report and
any accompanying images. A copy of the written
Table 1 Cases of neurobrucellosis with intracerebral granuloma.
Author/year Signs and symptoms Age/sex Lesion Analysis of granuloma, blood, CSF
samples
Treatment/duration/
result
Ciftci et al. [10]
1998
Visual impairment, bilateral
hearing loss,
hyperprolactinemia,
meningitis
25-year-old
female
Sellar and
suprasellar mass
STA, 1/320, and 1/160 in blood and
CSF, respectively
190 cells/mL (lymphocytes), protein
227 mg/dL, glucose 18 mg/dL in
CSF
TS, RIF, 10 weeks,
hearing loss
Sohn et al.
[11] 2003
Periorbital pain, headache,
generalized tonic-clonic
seizure
26-year-old
man
3 × 3 cm left
frontal lobe mass
Brucella spp. in granuloma culture
STA, 1/160, in blood
Surgery + TS, RIF, 2
months, recovery
Headache, nausea, vomiting,
progressive visual function
deterioration
15-year-old
boy
Granulomas in the
left occipital and
parietal lobes (TI
+contrast)
Brucella spp. in granuloma culture
Serology:negative
DS,RIF, GM (1 month
and then TMP/SMX),
1 year, visual acuity
deficits and brain
atrophy
Al-Sous et al.
[13] 2004
Headache, deafness,
papilledema, sensory ataxia,
areflexia
30-year-old
female
Enhancing
granuloma
suprasellar region
(TI+contrast)
STA, 1/1280, 2ME, 1/640, in CSF
Protein level: 80 mg/dL in CSF
DS,RIF, TMP/SMX, 4
months, complete
recovery
Miguel et al.
[12] 2006
Weakness of the right upper
and lower limbs, headache,
Broca’s aphasia
39-year-old
male
3 cm enhancing
mass lesion in the
left parietal lobe
(T1,T2 + contrast)
IgM and IgG antibodies by ELISA in
CSF and blood
10 cells (mostly lymphocytes),
protein 76 mg/dL, glucose 55 mg/
dL in CSF
DS, RIF, GM, 2
months, right
hemiparesis
Present case Headache, weakness in the
left arm, hypoesthesia,
speech disturbance,
imbalance, fever, diplopia,
6.7.cranial nerves
involvement, generalized
tonic-clonic seizures
17-year-old
boy
A granuloma in
the genus of the
right capsula
interna (T1-
contrast)
IgM and IgG antibodies by ELISA i n
the CSF and blood STA, 1/160, and
1/80 in blood and CSF, respectively
104 cells (lymphocytes, 86%), protein
250 mg/dL, glucose 22 mg/dlL in
CSF
DS, RF, TMP/SMX, 6
months, complete
recovery
Abbreviations DS: doxycyline; GM: gentamycine; RIF: rifampicin; TMP/SMX: trimethoprim/sulfamethoxazole; TS: tetracycline.
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Chief.
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